These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 25224610

  • 1. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, VOICE-C Study Team.
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [Abstract] [Full Text] [Related]

  • 2. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, Schwartz K, Laborde N, Soto-Torres L.
    PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
    [Abstract] [Full Text] [Related]

  • 3. Women and ARV-based HIV prevention - challenges and opportunities.
    Geary CW, Bukusi EA.
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19356. PubMed ID: 25224621
    [Abstract] [Full Text] [Related]

  • 4. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 5. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, Smit JA, Kimani J.
    J Int AIDS Soc; 2014 May; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [Abstract] [Full Text] [Related]

  • 6. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK, Mensch BS, Woeber K, Musara P, Etima J, van der Straten A.
    BMC Womens Health; 2019 Jan 25; 19(1):18. PubMed ID: 30683103
    [Abstract] [Full Text] [Related]

  • 7. ARV-based HIV prevention for women - where we are in 2014.
    Mastro TD, Sista N, Abdool-Karim Q.
    J Int AIDS Soc; 2014 Jan 25; 17(3 Suppl 2):19154. PubMed ID: 25224614
    [Abstract] [Full Text] [Related]

  • 8. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, MTN-003D Study Team.
    J Int AIDS Soc; 2016 Jan 25; 19(1):20875. PubMed ID: 27247202
    [Abstract] [Full Text] [Related]

  • 9. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA, Dada S, Martin CE, Mullick S.
    J Int AIDS Soc; 2024 May 25; 27(5):e26249. PubMed ID: 38695102
    [Abstract] [Full Text] [Related]

  • 10. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L, Morar N, Kapiga S, Ramjee G, Hayes R.
    J Acquir Immune Defic Syndr; 2020 Dec 01; 85(4):458-465. PubMed ID: 33136745
    [Abstract] [Full Text] [Related]

  • 11. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM.
    AIDS Behav; 2017 May 01; 21(5):1361-1375. PubMed ID: 27317411
    [Abstract] [Full Text] [Related]

  • 12. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S, Pack AP, Tolley EE, Ryan E, Mackenzie C, Bockh E, Githuka G.
    J Int AIDS Soc; 2014 May 01; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [Abstract] [Full Text] [Related]

  • 13. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.
    Thomson KA, Baeten JM, Mugo NR, Bekker LG, Celum CL, Heffron R.
    Curr Opin HIV AIDS; 2016 Jan 01; 11(1):18-26. PubMed ID: 26417954
    [Abstract] [Full Text] [Related]

  • 14. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
    van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, Taylor J, Piper J, Musara P, MTN-041/MAMMA Study Team.
    J Int AIDS Soc; 2020 Jun 01; 23(6):e25536. PubMed ID: 32524700
    [Abstract] [Full Text] [Related]

  • 15. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, Celum C, Delany-Moretlwe S, HPTN 082 study group.
    J Int AIDS Soc; 2020 Mar 01; 23(3):e25463. PubMed ID: 32144874
    [Abstract] [Full Text] [Related]

  • 16. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
    Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, Baeten JM.
    J Acquir Immune Defic Syndr; 2012 Sep 01; 61(1):116-9. PubMed ID: 22595872
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
    Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, Bekker LG.
    PLoS One; 2018 Sep 01; 13(2):e0191251. PubMed ID: 29420549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce IV, Reddy K, Friedland BA, Palanee-Phillips T, Mathur S.
    BMC Womens Health; 2024 Aug 22; 24(1):462. PubMed ID: 39174929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.